AbCellera Biologics Inc. — Investor Relations & Filings

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, full-stack technology platform that integrates biology, computation, and engineering to search and analyze natural immune systems for therapeutic antibodies. This engine is designed to accelerate the development of first-in-class and best-in-class medicines. AbCellera advances its own internal pipeline and also partners with other pharmaceutical and biotech companies to address challenging drug discovery problems. Its capabilities support programs involving complex targets such as transmembrane proteins, bispecifics, and antibody drug conjugates for conditions with high unmet medical need.